Clinical trials
Cognitive Dysfunction trials in Spain with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
89 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 3 |
| 2016 | 4 |
| 2017 | 5 |
| 2018 | 3 |
| 2019 | 5 |
| 2020 | 4 |
| 2021 | 9 |
| 2022 | 8 |
| 2023 | 12 |
| 2024 | 12 |
| 2025 | 10 |
| 2026 | 10 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 43 |
| Unknown status | 19 |
| Recruiting | 13 |
| Not yet recruiting | 5 |
| Active, not recruiting | 5 |
| Enrolling by invitation | 3 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Consorci Sanitari de Terrassa | 4 |
| University of Jaén | 4 |
| Fundacion Miguel Servet | 3 |
| Universidad Antonio de Nebrija | 3 |
| Universidad de Zaragoza | 3 |
| University of Salamanca | 3 |
| University of Valencia | 3 |
| Accexible | 2 |
| Badalona Serveis Assistencials | 2 |
| Barcelonabeta Brain Research Center, Pasqual Maragall Foundation | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cognitive Dysfunction | 89 |
| Alzheimer Disease | 11 |
| Dementia | 10 |
| Breast Neoplasms | 4 |
| Neurocognitive Disorders | 4 |
| Fatigue | 3 |
| Frailty | 3 |
| Metabolic Syndrome | 3 |
| Neoplasms | 3 |
| Sarcopenia | 3 |
Trials
Showing 1 to 25 of 89. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.